Minerva Neurosciences, Inc. (NERV) Stock Grade

About Minerva Neurosciences, Inc.'s fundamentals

Minerva Neurosciences is a biotechnology company with a market capitalization of $158.4 million that reported flat year-over-year revenue growth of 0.0% and no net profit, posting a net loss in its latest annual statement. The company does not pay a dividend and lacks a meaningful price-to-earnings ratio due to its unprofitable status. Despite the loss position, the company shows a notably high return on equity of 208.5%, though this metric can be volatile for loss-making companies with minimal or negative book value.